Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1952 4
1953 4
1954 5
1955 5
1956 4
1957 2
1958 3
1959 3
1960 5
1961 7
1962 15
1963 13
1964 15
1965 11
1966 9
1967 19
1968 13
1969 17
1970 20
1971 20
1972 33
1973 17
1974 41
1975 38
1976 42
1977 49
1978 55
1979 54
1980 53
1981 69
1982 88
1983 98
1984 120
1985 114
1986 107
1987 98
1988 122
1989 117
1990 93
1991 109
1992 119
1993 122
1994 126
1995 155
1996 144
1997 212
1998 166
1999 207
2000 213
2001 206
2002 223
2003 197
2004 238
2005 250
2006 259
2007 246
2008 267
2009 272
2010 266
2011 293
2012 351
2013 335
2014 362
2015 402
2016 399
2017 423
2018 385
2019 365
2020 438
2021 558
2022 488
2023 420
2024 478
2025 573
2026 459
2027 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,287 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean hamamoto s[Author] (404 results)?
Domain-adaptive semi-supervised learning for efficient rare pathological lesion detection with minimal annotation.
Matsui I, Matsumoto A, Imai A, Okushima H, Niioka H, Abe M, Tamai N, Nagasu H, Kanda E, Uchino E, Sofue T, Imasawa T, Yano Y, Kinashi H, Miyoshi KI, Harada T, Nagasawa Y, Fujimoto K, Kurokawa Y, Kato S, Kaseda R, Koizumi M, Kusunoki Y, Ohya M, Kawazoe Y, Abe H, Matsukuma Y, Kosugi T, Ueda Y, Fujii N, Takeji M, Suzuki A, Nagatoya K, Oka K, Ando Y, Izumi M, Komiya T, Tsukamoto T, Mimura I, Kuragano T, Nakano T, Tsuruya K, Ito Y, Minamino T, Yamaguchi O, Yamamoto S, Komaba H, Furuichi K, Fukami K, Araki SI, Masaki T, Tsuboi N, Yokoyama H, Shimizu A, Ushiku T, Maruyama S, Yanagita M, Nangaku M, Yamamoto R, Inoue K, Isaka Y. Matsui I, et al. Among authors: yamamoto s. NPJ Digit Med. 2025 Nov 23;8(1):778. doi: 10.1038/s41746-025-02160-6. NPJ Digit Med. 2025. PMID: 41276625 Free PMC article.
Sex differences in the incidence of composite ischemic and bleeding events in ischemic stroke patients with nonvalvular atrial fibrillation and atherosclerosis.
Morishita M, Uchida K, Yoshimura S, Okazaki S, Tanaka K, Yazawa Y, Doijiri R, Koga M, Ihara M, Yamamoto S, Yoshimoto T, Yamamoto H, Hirano T, Toyoda K, Sakai N, Yamagami H. Morishita M, et al. Among authors: yamamoto s. J Stroke Cerebrovasc Dis. 2026 May;35(5):108615. doi: 10.1016/j.jstrokecerebrovasdis.2026.108615. Epub 2026 Mar 21. J Stroke Cerebrovasc Dis. 2026. PMID: 41871638 Free article. Clinical Trial.
NRF2-COX2-PGE 2 axis drives immune cold tumors and predicts resistance to combination immunotherapy in hepatocellular carcinoma.
Yamamoto S, Kodama T, Kuwano A, Maesaka K, Yoshida-Hashidate T, Shindou H, Takeda H, Shirai K, Myojin Y, Murai K, Makino Y, Tahata Y, Saito Y, Hosui A, Nozaki Y, Nakabori T, Ohkawa K, Tanaka S, Nishio A, Miyazaki M, Hikita H, Motomura K, Lujambio A, Taketomi A, Eguchi H, Takehara T. Yamamoto S, et al. Hepatology. 2026 Jan 15. doi: 10.1097/HEP.0000000000001677. Online ahead of print. Hepatology. 2026. PMID: 41538242
Comparison of long-term survival between nivolumab plus ipilimumab with chemotherapy and pembrolizumab with chemotherapy in advanced non-small cell lung cancer: A multicenter retrospective cohort study.
Kinehara Y, Matsumoto K, Shiroyama T, Komuta K, Tamiya M, Nishino K, Tamiya A, Kuge T, Uchida J, Suzuki H, Yamamoto S, Tobita S, Niki T, Tetsumoto S, Morimura O, Osa A, Minami T, Nagatomo I, Takeda Y, Kijima T, Kumanogoh A. Kinehara Y, et al. Among authors: yamamoto s. Lung Cancer. 2026 Apr;214:109336. doi: 10.1016/j.lungcan.2026.109336. Epub 2026 Feb 19. Lung Cancer. 2026. PMID: 41723915 Free article.
Tofogliflozin ameliorates cardiotoxin induced skeletal muscle injury and fibrosis in obesity.
Bilal M, Phuong NQ, Kado T, Liu J, Anh LD, Khalid S, Aslam MR, Memoona, Nishimura A, Igarashi Y, Watanabe Y, Abbas W, Yokoyama M, Onogi Y, Hirabayashi K, Yamamoto S, Yagi K, Lino M, Usui I, Kato M, Fujisaka S, Nawaz A, Tobe K. Bilal M, et al. Among authors: yamamoto s. Sci Rep. 2025 Oct 22;15(1):32633. doi: 10.1038/s41598-025-12734-9. Sci Rep. 2025. PMID: 41125676 Free PMC article.
Deletion of fibro-adipogenic progenitors-specific follistatin impairs muscle function and accelerates skeletal muscle atrophy in obese mice.
Aslam MR, Bilal M, Nawaz A, Kado T, Abe S, Phuong NQ, Memoona, Khalid S, Anh LD, Nishimura A, Watanabe Y, Igarashi Y, Iqbal N, Yokoyama M, Onogi Y, Hirabayashi K, Miwa H, Era T, Matzuk MM, Yamamoto S, Ikuta K, Usui I, Kobayashi K, Satake T, Kato M, Fujisaka S, Tobe K. Aslam MR, et al. Among authors: yamamoto s. Mol Med. 2025 Nov 21;31(1):340. doi: 10.1186/s10020-025-01393-1. Mol Med. 2025. PMID: 41272451 Free PMC article.
Cardiac characteristics of Fabry disease from baseline enrolment data in a nationwide prospective Japanese registry.
Kubo T, Maekawa Y, Hongo K, Yamamoto S, Izumiya Y, Yamakawa H, Yano T, Higuchi K, Kuramoto Y, Nakagawa N, Amano M, Yamada Y, Oikawa M, Iida Y, Tsujita K, Matsue Y, Izawa H, Suzuki A, Nagatomo Y, Nagai T, Kida K, Nakamura K, Nakamura K, Ikenaga H, Kanda T, Kinugasa Y, Ito H, Onoue K, Kanamori H, Kitaoka H. Kubo T, et al. Among authors: yamamoto s. Int J Cardiol. 2026 Feb 15;445:134071. doi: 10.1016/j.ijcard.2025.134071. Epub 2025 Dec 4. Int J Cardiol. 2026. PMID: 41352439 Free article.
11,287 results
You have reached the last available page of results. Please see the User Guide for more information.